India · Delayed Price · Currency is INR Alivus Life Sciences Statistics
Total Valuation
NSE:ALIVUS has a market cap or net worth of INR 177.53 billion. The enterprise value is 167.94 billion.
| Market Cap | 177.53B |
| Enterprise Value | 167.94B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Sep 1, 2026 |
Share Statistics
NSE:ALIVUS has 122.77 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 122.77M |
| Shares Outstanding | 122.77M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 10.50% |
| Float | 34.55M |
Valuation Ratios
The trailing PE ratio is 26.57 and the forward PE ratio is 22.77.
| PE Ratio | 26.57 |
| Forward PE | 22.77 |
| PS Ratio | 6.61 |
| PB Ratio | 4.89 |
| P/TBV Ratio | 4.94 |
| P/FCF Ratio | 46.62 |
| P/OCF Ratio | 23.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.25, with an EV/FCF ratio of 44.10.
| EV / Earnings | 25.07 |
| EV / Sales | 6.26 |
| EV / EBITDA | 18.25 |
| EV / EBIT | 19.97 |
| EV / FCF | 44.10 |
Financial Position
The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.08 |
| Quick Ratio | 3.55 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.14 |
| Interest Coverage | 155.28 |
Financial Efficiency
Return on equity (ROE) is 20.15% and return on invested capital (ROIC) is 24.02%.
| Return on Equity (ROE) | 20.15% |
| Return on Assets (ROA) | 13.17% |
| Return on Invested Capital (ROIC) | 24.02% |
| Return on Capital Employed (ROCE) | 22.26% |
| Weighted Average Cost of Capital (WACC) | 4.55% |
| Revenue Per Employee | 11.82M |
| Profits Per Employee | 2.95M |
| Employee Count | 2,272 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.49 |
Taxes
In the past 12 months, NSE:ALIVUS has paid 2.19 billion in taxes.
| Income Tax | 2.19B |
| Effective Tax Rate | 24.61% |
Stock Price Statistics
The stock price has increased by +58.28% in the last 52 weeks. The beta is 0.05, so NSE:ALIVUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +58.28% |
| 50-Day Moving Average | 1,383.48 |
| 200-Day Moving Average | 1,150.36 |
| Relative Strength Index (RSI) | 54.27 |
| Average Volume (20 Days) | 419,348 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ALIVUS had revenue of INR 26.84 billion and earned 6.70 billion in profits. Earnings per share was 54.43.
| Revenue | 26.84B |
| Gross Profit | 15.65B |
| Operating Income | 8.41B |
| Pretax Income | 8.88B |
| Net Income | 6.70B |
| EBITDA | 9.13B |
| EBIT | 8.41B |
| Earnings Per Share (EPS) | 54.43 |
Balance Sheet
The company has 10.12 billion in cash and 529.00 million in debt, with a net cash position of 9.59 billion or 78.10 per share.
| Cash & Cash Equivalents | 10.12B |
| Total Debt | 529.00M |
| Net Cash | 9.59B |
| Net Cash Per Share | 78.10 |
| Equity (Book Value) | 36.31B |
| Book Value Per Share | 295.78 |
| Working Capital | 23.01B |
Cash Flow
In the last 12 months, operating cash flow was 7.64 billion and capital expenditures -3.84 billion, giving a free cash flow of 3.81 billion.
| Operating Cash Flow | 7.64B |
| Capital Expenditures | -3.84B |
| Depreciation & Amortization | 719.74M |
| Net Borrowing | -75.45M |
| Free Cash Flow | 3.81B |
| FCF Per Share | 31.02 |
Margins
Gross margin is 58.31%, with operating and profit margins of 31.33% and 24.95%.
| Gross Margin | 58.31% |
| Operating Margin | 31.33% |
| Pretax Margin | 33.09% |
| Profit Margin | 24.95% |
| EBITDA Margin | 34.01% |
| EBIT Margin | 31.33% |
| FCF Margin | 14.18% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.35%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.35% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.17% |
| FCF Payout Ratio | 16.12% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 0.25% |
| Earnings Yield | 3.76% |
| FCF Yield | 2.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:ALIVUS is 1,676.25, which is 15.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,676.25 |
| Price Target Difference | 15.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 12.91% |
| EPS Growth Forecast (3Y) | 18.70% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |